Doctor Care Pharma-Care Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 11 Year, 11 Days
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 2.33 Cr
- Satisfied Charges ₹ 4.00 M
- Revenue Growth 48.45%
- Profit Growth 755.66%
- Ebitda -63.52%
- Net Worth 0.49%
- Total Assets -8.63%
About Doctor Care Pharma-Care
Doctor Care Pharma-Care Private Limited (DCPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 February 2014 and has a history of 11 years. Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹2.33 Cr. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Hareshkumar Patel and Bhavanaben Patel serve as directors at the Company.
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239GJ2014PTC078692
- Company No.
078692
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Feb 2014
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Doctor Care Pharma-Care?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hareshkumar Patel  | Director | 11-Feb-2014 | Current |
| Bhavanaben Patel | Director | 11-Feb-2014 | Current |
Financial Performance of Doctor Care Pharma-Care.
Doctor Care Pharma-Care Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 48.45% increase. The company also saw a substantial improvement in profitability, with a 755.66% increase in profit. The company's net worth moved up by a moderate rise of 0.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Doctor Care Pharma-Care?
In 2020, Doctor Care Pharma-Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.33 Cr
₹0.40 Cr
Charges Breakdown by Lending Institutions
- Indian Bank : 2.33 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 May 2017 | Indian Bank | ₹2.33 Cr | Open |
| 08 Sep 2014 | The Cosmos Co-Operative Bank Ltd | ₹4.00 M | Satisfied |
How Many Employees Work at Doctor Care Pharma-Care?
Unlock and access historical data on people associated with Doctor Care Pharma-Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Doctor Care Pharma-Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doctor Care Pharma-Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.